Nutritional Status and Hidradenitis Suppurativa (Acne Inversa)
NCT ID: NCT03683238
Last Updated: 2018-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
81 participants
OBSERVATIONAL
2015-05-31
2018-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa
NCT01063270
Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa
NCT00494351
Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis Suppurativa
NCT06301256
Thyroid Dysfunction in Female Patients With Acne Vulgaris: [ Relation to Other Variables ]
NCT03602534
Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS).
NCT05997277
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mediterranean Diet
We aim to determine the effects of the traditional Mediterranean Diet on Hidradenitis suppurativa
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* treatment-naïve patients
* had HS diagnosed ≥6 months before study initiation wash out therapy for at least 3 months
Exclusion Criteria
* hypocaloric diet in the last three months or specific nutritional regimens;
* vitamin/mineral or antioxidant supplementation;
* occasional or current of use of drugs that could influence fluid balance, including non-steroidal anti-inflammatory drugs, hormone replacement therapy.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federico II University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Silvia Savastano
Associate Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201/15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.